Melissa Schwartz
Icahn School of Medicine at Mount Sinai
Uganda
About
No AI summary yet.
Metrics
- Publications
- 28
- Citations
- 306
- h-index
- 8
- Publishing journals
- 14
- Years of publications
- 20+
- Active since
- 2015
- References
- 256
- Institutions
- 5
Publication history
Latest publications
- Patient-reported outcomes following radiofrequency ablation of the hip: a retrospective study
- Sciatic-nerve radiofrequency ablation for phantom limb pain: A case report
- P20 Superficial myometrial invasion and chemotherapy are associated with improved outcomes in patients with stage 1 uterine carcinosarcoma
- Vulnerability of ARID1A deficient cancer cells to pyrimidine synthesis blockade
- Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
- Use of vaginal chlorhexidine antisepsis prior to hysterectomy to reduce surgical site infection
- Racial and socioeconomic disparities in treatment and survival for women with advanced endometrial cancer
- Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study
- Hysterectomy at the time of risk-reducing surgery in BRCA carriers
- Applying Precision Medicine to Ovarian Cancer
- Primary breast cancer of the vulva with concurrent breast and endometrial cancers: A case report and literature review
- Cervical cancer screening and treatment in Uganda
- Laparoscopic surgery for gynecologic cancer in low- and middle-income countries (LMICs): An area of need
- Spontaneous Rupture of a Leiomyoma Causing Life-Threatening Intra-Abdominal Hemorrhage
- The addition of chemotherapy to adjuvant radiotherapy in patients with intermediate-risk stage IB cervical cancer and the effect on survival
- Hysterectomy at the time of risk-reducing bilateral salpingo-oophorectomy amongst a cohort of women with BRCA gene mutations
- Thirty-day hospital readmission and mortality in advanced uterine cancer
- Patterns of care for FIGO stage IB-IIA cervical cancer across the United States
- Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin bevacizumab, docetaxel and cyclophosphamide (GFIP/BDC) for heavily pretreated epithelial ovarian (EOC), Fallopian tube (FT) and primary peritoneal (PP) cancer.
- Why We Fail. Single Dose Methotrexate Failure – Comparing Patients Receiving Second Dose with Those Selected for Surgical Intervention
No publications in the index yet.